FDA NDC Directory · JSON-LD · Markdown

Atovaquone

NDC 72603-248 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Labeler / ManufacturerNorthStar RxLLC
Marketing categoryAbbreviated NDA (generic) · App ANDA210692
Dosage form / routeSUSPENSION · ORAL
Active ingredientsATOVAQUONE (750 mg/5mL)
Marketing started20240501
Package count1

External sources

Source: openFDA. Public-domain (CC0).